IEQ Capital’s LeonaBio Inc LONA Stock Holding History

IEQ Capital’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,992	Closed	-$148K	–	818
2022 Q3	$148K	Hold	4,992	–	–	﹤0.01%	786
2022 Q2	$152K	Hold	4,992	–	–	﹤0.01%	748
2022 Q1	$674K	Hold	4,992	–	–	0.02%	420
2021 Q4	$650K	Sell	4,992 -5	-0.1%	-$632	0.02%	395
2021 Q3	$468K	Buy	4,997 +5	+0.1%	+$509	0.01%	449
2021 Q2	$511K	Buy	+4,992	New	+$872K	0.02%	362

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's LONA Position: Q4 2022 in Review

IEQ Capital sold out of LeonaBio Inc (LONA) in Q4 2022, closing a stake of 4,992 shares — an estimated $148K sold.

IEQ Capital first reported a position in LONA in Q2 2021 and held it in 6 quarters. The position peaked at $674K in Q1 2022. 92 funds tracked by Wall St. Rank hold LONA as of Q4 2022.

IEQ Capital reported no remaining LeonaBio Inc position as of Q4 2022 after selling out during the quarter.
IEQ Capital sold 4,992 LeonaBio Inc shares in Q4 2022, an estimated $148K.
IEQ Capital first reported a position in LeonaBio Inc in Q2 2021 and held it in 6 quarters.
IEQ Capital's LeonaBio Inc position peaked at $674K in Q1 2022.
92 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2022.

Based on IEQ Capital's 13F filing for Q4 2022, filed 6 Feb 2023.